Scarica l'app Stockscreener
4.44
1.11%
-0.05
Dopo l'orario di chiusura:
4.52
0.08
+1.80%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GDRX Giù?
Forum
Previsione
Precedente Chiudi:
$4.49
Aprire:
$4.48
Volume 24 ore:
3.23M
Relative Volume:
2.38
Capitalizzazione di mercato:
$1.69B
Reddito:
$775.09M
Utile/perdita netta:
$-58.68M
Rapporto P/E:
176.19
EPS:
0.0252
Flusso di cassa netto:
$64.06M
1 W Prestazione:
-5.73%
1M Prestazione:
+3.02%
6M Prestazione:
-43.08%
1 anno Prestazione:
-29.41%
Intervallo 1D:
$4.40
$4.63
Intervallo di 1 settimana:
$4.32
$4.755
Portata 52W:
$4.09
$9.2599
Goodrx Holdings Inc Stock (GDRX) Company Profile
Nome
Goodrx Holdings Inc
Settore
Industria
Telefono
(855) 268-2822
Indirizzo
2701 OLYMPIC BOULEVARD, SANTA MONICA
Confronta GDRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
4.44 | 1.69B | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
224.15 | 36.39B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
66.83 | 11.55B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
57.83 | 10.80B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
94.95 | 8.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.82 | 6.34B | 906.14M | -52.62M | 89.62M | -0.3621 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-08-09 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-05-23 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-05-16 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2024-04-10 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-03-25 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-03-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-02 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-08-10 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2023-07-31 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2022-12-01 | Iniziato | Citigroup | Buy |
| 2022-11-04 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-12 | Iniziato | DA Davidson | Neutral |
| 2022-06-10 | Downgrade | Goldman | Buy → Neutral |
| 2022-06-06 | Ripresa | BofA Securities | Buy |
| 2022-06-01 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-05-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-05-10 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-05-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-05-10 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | Iniziato | Wells Fargo | Equal Weight |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2022-03-15 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-03-01 | Reiterato | Barclays | Overweight |
| 2022-03-01 | Reiterato | BofA Securities | Neutral |
| 2022-03-01 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-03-01 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-03-01 | Reiterato | Evercore ISI | Outperform |
| 2022-03-01 | Reiterato | Goldman | Buy |
| 2022-03-01 | Reiterato | JP Morgan | Underweight |
| 2022-03-01 | Reiterato | RBC Capital Mkts | Outperform |
| 2022-03-01 | Reiterato | SVB Leerink | Outperform |
| 2022-01-07 | Iniziato | Goldman | Buy |
| 2021-12-21 | Iniziato | Stephens | Overweight |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-08-31 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-08-13 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2021-05-28 | Iniziato | Robert W. Baird | Neutral |
| 2021-04-06 | Ripresa | Evercore ISI | Outperform |
| 2021-01-25 | Iniziato | Guggenheim | Buy |
| 2020-11-19 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-19 | Iniziato | Barclays | Equal Weight |
| 2020-10-19 | Iniziato | BofA Securities | Neutral |
| 2020-10-19 | Iniziato | Citigroup | Buy |
| 2020-10-19 | Iniziato | Cowen | Outperform |
| 2020-10-19 | Iniziato | Credit Suisse | Outperform |
| 2020-10-19 | Iniziato | Deutsche Bank | Hold |
| 2020-10-19 | Iniziato | Goldman | Neutral |
| 2020-10-19 | Iniziato | JP Morgan | Neutral |
| 2020-10-19 | Iniziato | Morgan Stanley | Overweight |
| 2020-10-19 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2020-10-19 | Iniziato | SVB Leerink | Outperform |
| 2020-10-19 | Iniziato | UBS | Buy |
Mostra tutto
Goodrx Holdings Inc Borsa (GDRX) Ultime notizie
GoodRx to Present at J.P. Morgan's Prestigious Healthcare Conference in January 2025 - StockTitan
GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
GoodRx Holdings, Inc. Appoints Wendy Barnes as CEO Starting January 1, 2025 - Marketscreener.com
GoodRx names new CEO - Houston Business Journal
Morgan Stanley Has Lowered Expectations for GoodRx (NASDAQ:GDRX) Stock Price - MarketBeat
GoodRx Report: 70% of U.S. Counties Face Critical Endocrinologist Shortage, 50M Americans Affected - StockTitan
GoodRx stock rises 5% after new CEO appointment - Investing.com
GoodRx stock rises 5% after new CEO appointment By Investing.com - Investing.com UK
GoodRx names Wendy Barnes as new CEO and President - Investing.com
GoodRx Holdings Appoints Wendy Barnes as CEO - TipRanks
GoodRx names Wendy Barnes as new CEO and President By Investing.com - Investing.com UK
GoodRx Names Wendy Barnes as New CEO - MarketWatch
GoodRx appoints Wendy Barnes as new CEO - Investing.com
GoodRx Names Healthcare Veteran Wendy Barnes as New CEO to Drive Growth Strategy - StockTitan
Charles Schwab Investment Management Inc. Boosts Stake in GoodRx Holdings, Inc. (NASDAQ:GDRX) - Defense World
Fortem Financial Group LLC Takes Position in GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat
Is GoodRx Holdings (GDRX) the Best NASDAQ Penny Stock to Buy Right Now? - Insider Monkey
11 Best NASDAQ Penny Stocks To Buy Right Now - Insider Monkey
GoodRx Agrees to Settle Data-Sharing Lawsuit for $25 Million - ClassAction.org
Kuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law Firm - The Eastern Progress Online
Pier Capital LLC Makes New $3.26 Million Investment in GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat
Point72 Asset Management L.P. Acquires New Holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat
GoodRx Inks $25M Deal With Users Over Alleged Data-Sharing - Law360
GoodRx Holdings, Inc. (NASDAQ:GDRX) Short Interest Update - MarketBeat
GoodRx (NASDAQ:GDRX) Shares Gap UpHere's Why - MarketBeat
Rubric Capital Management LP Increases Stock Holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives $8.86 Average Price Target from Brokerages - MarketBeat
Class Action Filed Against GoodRx Holdings, Inc. (GDRX) Seeking Recovery for InvestorsContact Levi & Korsinsky - GuruFocus.com
US Penny Stocks To Consider In November 2024 - Simply Wall St
GoodRx (NASDAQ:GDRX) Trading Up 8.2%Time to Buy? - MarketBeat
GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares Sold by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Why GoodRx Holdings Stock Was Sinking This Week - MSN
GoodRx Holdings, Inc. (GDRX) Misses Q3 Earnings and Revenue Estimates - MSN
GoodRx (NASDAQ:GDRX) Sees Large Volume IncreaseWhat's Next? - MarketBeat
GoodRx (NASDAQ:GDRX) Shares Down 7.5%Here's Why - MarketBeat
AMERIPRISE FINANCIAL INC's Strategic Reduction in GoodRx Holdings Inc - GuruFocus.com
Rubric Capital Management LP's Strategic Acquisition in GoodRx H - GuruFocus.com
GoodRx stock hits 52-week low at $4.66 amid market challenges - Investing.com India
GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Barclays Has Lowered Expectations for GoodRx (NASDAQ:GDRX) Stock Price - MarketBeat
GoodRx Holdings Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Reviewing TELUS International (Cda) (NYSE:TIXT) & GoodRx (NASDAQ:GDRX) - Defense World
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q3 2024 Earnings Call Transcript - Insider Monkey
Why GoodRx Holdings (GDRX) Stock is Moving Today - GuruFocus.com
Why GoodRx Holdings Stock Was Sinking This Week - The Motley Fool
GoodRx Holdings Inc (GDRX) Q3 2024 Earnings Call Highlights: Str - GuruFocus.com
GoodRx Holdings Inc (GDRX) Q3 2024 Earnings Call Highlights: Strong Financial Performance ... By GuruFocus - Investing.com Canada
GoodRx Holdings Inc (GDRX) Q3 2024 Earnings Call Highlights: Strong Financial Performance ... - Yahoo Finance
GoodRx Holdings Reports Strong Q3 2024 Performance - TipRanks
GoodRx (GDRX) Q3 2024 Earnings Call Transcript - Yahoo Finance
Goodrx Holdings Inc Azioni (GDRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Goodrx Holdings Inc Azioni (GDRX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Spectrum Equity VII, L.P. | 10% Owner |
Sep 03 '24 |
Sale |
7.86 |
10,677 |
83,922 |
0 |
1.16%
0.30%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):